Fig. 1.
Description of nanoparticles. (A) Schematic representation of nanoparticles surface modified with avidin to facilitate binding of a biotinylated ligand (not to scale). (B) Scanning electron microscopy image of surface modified nanoparticles. (C) Measurement of size and polydispersity of unmodified and surface modified nanoparticles by dynamic light scattering.